Hematology News

In a case study of three patients with COVID-19 vaccine-induced immune thrombotic thrombocytopenia, starting intravenous immune globulin was linked to reduced antibody-induced platelet activation in serum, according to data.

Lachelle Dawn Weeks, MD, PhD, of Dana-Farber Cancer Institute and Emilio Ramos, MD, PhD, of University of California, San Francisco, received the ASH-Harold Amos Medical Faculty Development Program Award.

Many individuals with cancer lack adequate immune defense against the measles and mumps viruses, according to a study conducted by researchers at Fred Hutchinson Cancer Research Center and published in JAMA Network Open.

Patients hospitalized with COVID-19 remain at higher risk for thromboembolic events and death after discharge than previously thought, according to study results published in Blood.

COVID-19 convalescent plasma administered within 7 days of symptom onset did not appear to prevent disease progression among high-risk outpatients with COVID-19, according to study results published in The New England Journal of Medicine.

Low platelet count and intracranial hemorrhage appeared associated with increased risk for death among hospitalized patients with COVID-19 vaccine-induced immune thrombocytopenia and thrombosis, according to study results.

The FDA issued a complete response letter to FibroGen indicating it cannot approve the company’s new drug application that seeks approval of roxadustat for anemia of chronic kidney disease.

Individuals with sickle cell disease or trait demonstrated a higher risk for COVID-19 hospitalization and death than individuals without these conditions, according to study findings published in Annals of Internal Medicine.

Therapeutic anticoagulation with heparin increased the likelihood of survival among noncritically ill patients who were hospitalized with COVID-19, according to a new study in The New England Journal of Medicine.

Anemia is a global public health problem that carries significant risk for mortality and morbidity, particularly among older adults, children and individuals with chronic conditions.